Navigation Links
University Hospitals Chief Executive Officer Extends Contract
Date:12/20/2007

Thomas F. Zenty III to continue to lead UH's Historic Vision 2010 Strategic

Plan

CLEVELAND, Dec. 20 /PRNewswire/ -- University Hospitals Board of Directors has announced that Thomas F. Zenty III, Chief Executive Officer, University Hospitals, has agreed to serve as the health system's leader for an additional five years, through December 2012.

Monte Ahuja, Chairman of the UH Board of Directors, said, "I join my Board colleagues in underscoring our support for Tom and his community focused, dynamic and results-driven leadership of our health system. We look forward to working with him over the next five years to continue the momentum he has established for creating a healthier community in Northeast Ohio, an integral part of our vision for University Hospitals in 2010 and beyond."

Since joining University Hospitals (UH) in 2003 as the President and Chief Executive Officer of the health system, Mr. Zenty has worked closely with the Board of Directors, system leadership team, employees and community leaders to build a strong foundation for University Hospitals that will ensure the delivery of the highest quality patient-centered healthcare in Northeast Ohio and the nation.

Most notably, Mr. Zenty has led UH's bold and historic strategic plan, Vision 2010. Under his guidance, UH has made great strides toward achieving this vision. This year, UH has completed construction of the UH Twinsburg Health Center and broken ground for the UH Ahuja Medical Center in Beachwood. UH has also made significant investments to its main campus in Cleveland -- UH Case Medical Center -- including finalizing plans to build a new free-standing cancer hospital, Neonatal Intensive Care Unit, and Center for Emergency Medicine. UH continues to make significant investments in its community medical centers throughout the region.

During Mr. Zenty's tenure, UH has bolstered its commitment to the community by providing charit
'/>"/>

SOURCE University Hospitals
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. University of Iowa professor identifies new eating disorder
2. University of Wisconsin Hospitals and Clinics Complete System-Wide Conversion to Masimo SET Pulse Oximetry Technology
3. University of Texas Study Details Lengthy Payment Delays for Medicare Part D Prescription Drug Claims, Confirming Need for Legislative Fix
4. Tulane University to receive $14M for international HIV/AIDS program
5. University of Nevada School of Medicine Professor Confirms Accuracy Through Validation Study Using the CSI Health Station Model 6K
6. Boston University School of Medicine researcher recipient of Memory Ride Grant
7. Loma Linda University Medical Center Selects Beryl to Manage Call Center Interactions for Womens Services Programs and Departments
8. Medina General Hospital and University Hospitals Agree to Pursue Affiliation
9. J.D. Power and Associates Reports: Hackensack University Medical Center Recognized as First Hospital to Achieve Distinction for Providing an Outstanding Inpatient Experience in All Four Service Areas
10. The First Incisionless Transoral Fundoplication for Treatment of Gastroesophageal Reflux is Performed in the U.S. at Ohio State University and Oregon Health & Science University Medical Centers
11. George Mason University professor receives $2.6 million NIH grant to study Alzheimers disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...ov. 21 A prestigious group of phys...ll gather in Williamsburg, VA on March 27-29, 2009...nical information on cutting-edge therapeutic prot... research advances that impact patient care. The f...ion information is available at www.bioconference...
(Date:11/21/2008)...wswire/ -- Innerscope Research(TM), a revolutionar...motional Response Measurement,announced today th...hen the,company,s research and development, busin...The three appointments, who deliver a combined 60 ...ef Financial Officer and Vice President of,Strate...
(Date:11/21/2008)...ma - The University of Texas M. D. Anderson Cancer...fort to eradicate breast cancer in Panama through ...search of the Americas today at an event with Laur...ivian Fernndez de Torrijos, the First Lady of Pana... are the U.S. Department of State and Susan G. Kom...
(Date:11/21/2008)... Three Minnesotans who successfully...ecial on-ice presentation at,the Minnesota Wild g...winners,were participants in The QuitCash Challen...esota(SM) and QUITPLAN(R) Services. , The g...le two runners-up,will get $1,000 gift cards from...
Breaking Medicine News(10 mins):Health News:17th Annual Congress on Women's Health Convenes March 27-29, 2009 in Williamsburg, VA 2Health News:Innerscope Research Strengthens Management Team With Three Executive Appointments 2Health News:First Lady Laura Bush's Partnership for Breast Cancer Awareness and Research extends to Panama 2Health News:Lucky Quitters to Receive Big Money in Stop-Smoking Contest 2
...red a cocktail of enzymes that converts starchy sy...ter can be fed into a fuel cell to run an electric...ne. The method hinges on a mixture of 13 enzymes...ely in plants, rabbits, bacteria and yeast, but ne...
... the University of Missouri-Columbia; is of the vi...ld be a good source for cattle feed. In his stud... at the College of Agriculture, is examining the e...n as cattle feed. Through November, Kerley will ...
...aralysed in a Bihar district as hundreds of doctor...olice in rescuing two abducted school students wh...Doctors in Begusarai district, about 125 km from t... strike Thursday to protest the failure of the pol...
...e American Academy of Neurology finds conventional...ffective for treating nervous system Lyme disease....olonged treatment with antibiotics has any benefit...dard therapy. The guideline is published May 23, 2...
Other Medicine News:Health News:Researchers Discover Starch Cocktail Fuel for green Car 2Health News:Study Finds Glycerin to Be a Good Source for Cattle Feed 2Health News:Antibiotics Highly Effective for Treating Lyme Disease 2
(Date:11/20/2008)...Newswire-FirstCall/ -- Bionovo, Inc.,(Nasdaq: B...rom the Phase 1B,clinical trial of their lead dru..., BZL101, at the Society for Integrative Oncology,...gia. The Company,s oral presentation was selected...as a part of the Best of the,SIO Session on Novem...
(Date:11/20/2008)...stCall/ -- PAREXEL International Corporation (Nasd...ervices provider, today announced that it has open...onsulting and clinical research capabilities. With...locations throughout five important biopharmaceuti...rgentina, Brazil, Chile, and Mexico. This expansio...
(Date:11/19/2008)...ve statistical significance , , ISELIN, N.J...oration (Nasdaq: PARS ) today announced results ...noEmulsion (NE) drug delivery technology formulate...e multi-center, randomized, double-blinded, placeb...cy of the Company,s 3% Diclofenac Diethanolamine N...
(Date:11/19/2008)...om Roche- , , MONTVALE, N.J., Nov. 19 /PRNe...(Nasdaq: MEMY ) today announced that it has achi...R3487/MEM 3454, its lead alpha-7 nicotinic recepto... schizophrenia (CIAS). The Company has randomized...5.0 million payment from its partner Roche. Memor...
Breaking Medicine Technology:Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 2Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 3Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 4Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 5PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 2PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 3PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 4Pharmos Announces Clinical Results from Phase 2a Trial of Topical Diclofenac NanoEmulsion Cream 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 3Simulating kernel production influences maize model accuracy 501 1Simulating kernel production influences maize model accuracy 501 2Metagenomics of the deep Mediterranean 497 1Metagenomics of the deep Mediterranean 497 2Smithsonian identifies invasive crab species in Panama Canal expansion area 493 1Smithsonian identifies invasive crab species in Panama Canal expansion area 493 2Bone growing nanomaterial could improve orthopaedic implants 743 1Bone growing nanomaterial could improve orthopaedic implants 743 2
...AGO--(BUSINESS WIRE)--Jun 4, 2007 - Genentech, Inc...a joint analysis of two Phase,III clinical trials ...nt treatment of HER2-positive breast cancer. Data ...an Society of Clinical,Oncology (ASCO) showed that... addition of Herceptin to standard adjuvant therap...
...ENHAGEN, June 3, 2007 - Genmab A/S (CSE: GEN) ann...lly human,HuMax-EGFr™ (zalutumumab) antibody...er-express several types of EGFr (epidermal,growth...ear to alter the signaling ability,of EGFr have be...,Such mutations may be a critical factor in the po...
Other Medicine Technology:Updated Overall Survival Data From Pivotal Herceptin Adjuvant,Studies in HER2-Positive Breast Cancer 2Updated Overall Survival Data From Pivotal Herceptin Adjuvant,Studies in HER2-Positive Breast Cancer 3Updated Overall Survival Data From Pivotal Herceptin Adjuvant,Studies in HER2-Positive Breast Cancer 4Updated Overall Survival Data From Pivotal Herceptin Adjuvant,Studies in HER2-Positive Breast Cancer 5Updated Overall Survival Data From Pivotal Herceptin Adjuvant,Studies in HER2-Positive Breast Cancer 6
The Professional ophthalmoscope has been designed to ensure ultimate control. Lenses, graticules and filters can all be introduced at the touch of a fingertip without the need to pull away from the p
...stem (iQ200 Sprint) is a user-friendly, bench top,...nalyses on un-spun specimens; simply load and walk...y facility looking to reduce turnaround time. The ... per hour and with the optional Load/Unload Statio...
The PDM utilizes the latest technology for measuring interpupillary distance and left/right pupil-to-nose distance. Lightweight and easy-to-use, the PDM provides accurate and repeatable PD measuremen
VACUETTE® Tube Holders should be used exclusively with VACUETTE® Blood Collection Needles as both components are designed for optimal compatibility with one another.
Medicine Products: